z-logo
open-access-imgOpen Access
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Author(s) -
Veeru Kasivisvanathan,
Antti Rannikko,
Marcelo Borghi,
Valeria Panebianco,
Lance A. Mynderse,
Markku H. Vaarala,
Alberto Briganti,
Lars Budäus,
Giles Hellawell,
Richard G. Hindley,
Monique J. Roobol,
Scott E. Eggener,
Maneesh Ghei,
Arnauld Villers,
Franck Bladou,
Geert Villeirs,
Jaspal Virdi,
Silvan Boxler,
G. Robert,
Paras B. Singh,
Wulphert Venderink,
Boris Hadaschik,
A. Ruffion,
Jim C. Hu,
Daniel Margolis,
Sébastien Crouzet,
Laurence Klotz,
Samir S. Taneja,
Peter A. Pinto,
Inderbir S. Gill,
Clare Allen,
Francesco Giganti,
Alex Freeman,
Stephen Morris,
Shonit Punwani,
Norman Williams,
Chris BrewGraves,
Jonathan J Deeks,
Yemisi Takwoingi,
Mark Emberton,
Caroline M. Moore
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1801993
Subject(s) - biopsy , medicine , prostate cancer , transrectal ultrasonography , prostate biopsy , radiology , cancer , prostate , magnetic resonance imaging , confidence interval
Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence is limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom